August 2006
Worldwide Biotech;Aug2006, Vol. 18 Issue 8, p7
Trade Publication
Announces the presentation of the Yorkshire Bioscience Award for International Achievement to Xceleron, a service provider specializing in zeptoanalysis to accelerate drug development in Great Britain. Purpose of the award; Achievements of Xceleron.


Related Articles

  • A testing approach based on tiny doses still awaits big results. Coombs, Amy // Nature Medicine;Aug2008, Vol. 14 Issue 8, p796 

    The article provides information on the first comparative human 'microdose' studies conducted by bioscience company Xceleron in the U.S. It cites that microgram-sized quantities of a drug are delivered to human subjects long before safety and efficacy trials have started. According to the...

  • Life sciences in brief.  // Chemical Market Reporter;11/7/2005, Vol. 268 Issue 16, p25 

    Reports developments related to life sciences in the U.S. Acquisition of the oncology product candidates GCR-3888 and GCR-8015 by Cambridge Antibody Technology from Genencor International Inc.; Details on the approval received by Genentech Inc. and OSI Pharmaceuticals Inc. from the Food and Drug...

  • Still Breathing. Abejo, Jerry // Mergers & Acquisitions: The Dealermaker's Journal;Jun2008, Vol. 43 Issue 6, p64 

    The article reports that field of Life science merger and acquisition (M&A) has a belief that pharmaceutical dealings were immune to the deal market's ups and downs. It is averred that dealmakers are pressured to think long-term due to the patient and unsure nature of drug development. It is...

  • Nanotech, Big Value. Studt, Tim // Drug Discovery & Development;Jun2002, Vol. 5 Issue 6, p9 

    Editorial. Comments on the less-than-accurate outcome of techological forecasts and its implications for the life sciences. Actual life sciences applications of nanotechnologies which were not considered potentially applicable technologies ten years earlier; Low number of new drugs in the...

  • Sweden leads EU in developing new antibiotics. Webster, Paul Christopher // CMAJ: Canadian Medical Association Journal;2/4/2014, Vol. 186 Issue 2, pE84 

    The article discusses the role of Sweden in antibiotic development as of February 2014. Topics discussed include the announcement by Swedish government in 2013 that it would double its investment in life science through 2016, the start of Sweden's leadership in antibiotic control in 1986, and...

  • Is Microfluidics Equipped for HTS? Boguslavsky, Julia // Bio-IT World;May2004, Vol. 3 Issue 5, p70 

    Deals with the trend toward the adoption of microfluidics technologies for high-throughput screening platforms by pharmaceutical companies in the U.S. in 2004. Launch of LabChip 3000 Drug Discovery system by Caliper Life Sciences; Information on the LabChip 3000; Benefits of the microfluidics...

  • Microdosing in Phase 0. Arnum, Patricia Van // Pharmaceutical Technology;Aug2008 Supplement, p48 

    An interview with J. Scott Tarrant, executive vice-president of Xceleron is presented. Tarrant explains the importance of microdosing in drug development since it acts as the administration of subpharmacologic doses of experimental drugs to human volunteers. He offers a brief discussion about...

  • In the Money.  // European Pharmaceutical Executive;Jul/Aug2005, p14 

    The article reports developments on the financial aspects of pharmaceutical companies in Europe. Xceleron company declared the closing of a new funding round of 2 million pounds intended for its working capital and for financing. The initial public offering of Arpida company in connection of its...

  • ATM Financing Provides Effective Access to Cash. Winter, Peter // BioWorld Insight;8/20/2012, Vol. 20 Issue 34, p1 

    The article presents a report on at-the-market (ATM) finance employed by the life science industry in the U.S. to fuel their drug development programs. It reports that the U.S. life science companies have raised a record to 90 million U.S. dollars through 20 ATM. It presents that flexibility and...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics